FRANKLIN M BERGER
CIK 1273885 · Director · last filed 2026-05-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.27M
Companies
13
Total Filings
116
Lifetime Open-Market Net
$11.27M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Kezar Life Sciences, Inc. (KZR) Delisted | Director | 0 | $7.29 | $0 | $2.91M | 14 | 2026-05-11 |
| AVIR | Director | 506,497 | $4.49 | $2.27M | -$238.2K | 12 | 2025-06-24 |
| ESSA Pharma Inc. (EPIX) Delisted | Director | 784,404 | $0.20 | $157.8K | $1.36M | 8 | 2024-03-28 |
| RAIN | Director | 0 | $2.04 | $0 | $3.41M | 8 | 2024-01-26 |
| Atreca, Inc. (BCEL) Delisted | Director | 97,808 | $0.15 | $14.7K | $0 | 5 | 2023-06-15 |
| FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | Director | 0 | $38.00 | $0 | $1.20M | 13 | 2021-04-19 |
| KINETA, INC./DE (PTI) Delisted | Director | 306,162 | — | — | $2.12M | 10 | 2020-07-01 |
| Forte Biosciences, Inc. (TOCA) Delisted | Director | 25,335 | — | — | $0 | 4 | 2019-10-04 |
| FIVE PRIME THERAPEUTICS, INC. (XLRN) Delisted | Director | — | $178.75 | — | $0 | 4 | 2019-06-12 |
| Seagen Inc. (SGEN) Delisted | Director | 204,720 | $228.74 | $46.83M | $505.2K | 20 | 2014-02-25 |
| Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Director | 500 | — | — | $1.9K | 2 | 2013-08-22 |
| EMIS | Director | — | $10.15 | — | $0 | 1 | 2009-05-19 |
| Diadexus, Inc. (AXC) Delisted | Director | — | — | — | $0 | 1 | 2008-06-11 |
Recent Filings · Page 4 of 12
116 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-09-23 | RAIN | Buy (P) | +3,786 | $54.1K | EDGAR |
| 2021-06-30 | Kezar Life Sciences, Inc. (KZR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-21 | AVIR | Grant (A) | — | $0 | EDGAR |
| 2021-06-11 | Atreca, Inc. (BCEL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-05-18 | RAIN | Grant (A) | — | $0 | EDGAR |
| 2021-04-27 | RAIN | Mixed | +836,540 | $2.12M | EDGAR |
| 2021-04-19 | FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | Disp (D) | −5,000 | -$190.0K | EDGAR |
| 2021-03-04 | ESSA Pharma Inc. (EPIX) Delisted | Buy (P) | +57,000 | $1.54M | EDGAR |
| 2021-01-26 | ESSA Pharma Inc. (EPIX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-01-11 | ESSA Pharma Inc. (EPIX) Delisted | Mixed | +42,207 | $153.7K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.